| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,620 |
2,364 |
$188K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
391 |
369 |
$22K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
414 |
413 |
$8K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
719 |
719 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
32 |
32 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
42 |
40 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
53 |
53 |
$645.37 |
| 87430 |
|
29 |
29 |
$373.23 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
12 |
12 |
$282.96 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
18 |
17 |
$216.90 |
| 85018 |
|
63 |
63 |
$163.78 |